Recent developments in fluorescence cystoscopy: Do novel agents bring a benefit?

Current Opinion in Urology

Volumn 17, Issue 5, 2007, Pages 347-351

  Schmidbauer, Jörg ^a   Marberger, Michael ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bladder cancer; Fluorescence cystoscopy; Photodynamic diagnosis

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; HYPERICIN;

BLADDER CANCER; BLEACHING; CANCER RECURRENCE; CARCINOMA IN SITU; CYSTOSCOPY; FLUORESCENCE CYSTOSCOPY; HUMAN; MULTIPLE CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; UROTHELIUM;

AMINOLEVULINIC ACID; CARCINOMA IN SITU; CYSTOSCOPY; FLUORESCENCE; FLUORESCENT DYES; HUMANS; PERYLENE; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 34548301672     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282c8c73f     Document Type: Review

References (30)

1. Van der Meijden AP, Sylvester R, Oosterlinck W, et al. EAU Guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 2005; 48: 363-371.
2. Van der Meijden AP, et al. Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol 1999; 35:267-271.
3. May F, Treiber U, Hartung R, et al. Significance of random bladder biopsies in superficial bladder cancer. Eur Urol 2003; 44:47-50.
4. Whitmore WF, Bush IM, Esquival E. Tetracycline ultraviolet fluorescence in bladder carcinoma. Cancer 1964; 17:1528-1532.
5. Agostinis P, Vantieghem A, Merlevede W, et al. Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 2002; 34:221-241.
6. Kamuhabwa AA, Cosserat-Gerardin I, Didelon J, et al. Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy. Int J Cancer 2002; 97:252-260.
7. D'Hallewin MA, De Witte PA, Waelkens E, et al. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 2000; 164:349-351.
8. D'Hallewin MA, Kamuhabwa AA, Roskams T, et al. Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 2002; 89:760-763.
9. D'Hallewin MA, Bezdetnaya L, Guillemin F. Fluorescence detection of bladder cancer: a review. Eur Urol 2002; 42:417-425.
10. Sim HG, Lau WKO, Olivo M, et al. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? BJU Int 2005; 95:1215-1218.
11. Olivo M, Lau W, Manivasager V, et al. Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin. Int J Oncol 2003; 23:1501-1504.
12. Datta SN, Loh CS, MacRobert AJ, et al. Quantitative studies of the kinetics of 5-aminolevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br J Cancer 1998; 78:1113-1118.
13. Kriegmair M, Baumgartner R, Knuechel R, et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994; 44:836-841.
14. Hungerhuber E, Stepp H, Kriegmair M, et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007; 69:260-264.
15. Riedl CR, Daniltchenko D, Koenig F, et al. Fluorescence endoscopy with 5-aminolevulinic acid reduces the early recurrence rate in bladder cancer. J Urol 2001; 165:1121-1125.
16. Babjuk M, Soukup V, Petrik R, et al. 5-Aminolevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/1 bladder cancer. BJU Int 2005; 96:798-802.
17. Daniltchenko DI, Riedl CR, Sachs MD, et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005; 174:2129-2133.
18. Denzinger S, Burger M, Walter B, et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007; 68:675-679.
19. Zaak D, Hungerhuber E, Schneede P, et al. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer 2002; 95:1234-1238.
20. Landry JL, Gelet A, Bouvier R, et al. Detection of bladder dysplasia using 5-aminolevulinic acid-induced porphyrin fluorescence. BJU Int 2003; 91: 623-626.
21. Grimbergen MC, Van Swol CF, Jonges TG, et al. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 2003; 44:51-56.
22. Marti A, Lange N, Van den Bergh H, et al. Optimization of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol 1999; 162:546-552.
23. Marti A, Jichlinski P, Lange N, et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 2003; 170:428-432.
24. Jichlinski P, Guillou L, Karlsen SJ, et al. Hexyl-aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer - a multicenter study. J Urol 2003; 170:226-229.
25. Schmidbauer J, Witjes F, Schmeller N, et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004; 171:135-138.
26. Jocham D, Witjes F, Wagner S, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005; 174:862-866.
27. Loidl W, Schmidbauer J, Susani M, et al. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance. Eur Urol 2005; 47:323-326.
28. Witjes JA, Moonen PM, Van der Meijden AG. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy in bladder cancer: results of a prospective phase II study. Eur Urol 2005; 47:319-322.
29. Frampton JE, Plosker GL. Hexyl aminolevulinate in the detection of bladder cancer. Drugs 2006; 66:571-578.
30. Jichlinski P, Leisinger HJ. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologists. Urol Int 2005; 74:97-101.